Home

Chronický Přijatelný Austrálie cervical cancer markers Pozoruhodný Závěr Chceteli zakázat

First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical  Benefit, Tolerability and Tumor Markers | Anticancer Research
First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research

Cervical cancer stem cell‑associated genes: Prognostic implications in cervical  cancer (Review)
Cervical cancer stem cell‑associated genes: Prognostic implications in cervical cancer (Review)

Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic  Scholar
Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic Scholar

Cancers | Free Full-Text | Targeted Gene Delivery Therapies for Cervical  Cancer
Cancers | Free Full-Text | Targeted Gene Delivery Therapies for Cervical Cancer

Bevacizumab in the Treatment of Cervical Cancer – Current Evidence and Next  Steps - touchONCOLOGY
Bevacizumab in the Treatment of Cervical Cancer – Current Evidence and Next Steps - touchONCOLOGY

DRH1 – a novel blood-based HPV tumour marker - eBioMedicine
DRH1 – a novel blood-based HPV tumour marker - eBioMedicine

IJMS | Free Full-Text | Low P16INK4A Expression Associated with High  Expression of Cancer Stem Cell Markers Predicts Poor Prognosis in Cervical  Cancer after Radiotherapy
IJMS | Free Full-Text | Low P16INK4A Expression Associated with High Expression of Cancer Stem Cell Markers Predicts Poor Prognosis in Cervical Cancer after Radiotherapy

Gene expression profiling identifies the role of Zac1 in cervical cancer  metastasis | Scientific Reports
Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis | Scientific Reports

Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic  Scholar
Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic Scholar

Table I from CYFRA 21.1 in patients with cervical cancer: comparison with  SCC and CEA. | Semantic Scholar
Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar

Tumor Markers - CA153/proGRP/CA242/PGI/PGII/Cy211 | Fapon Biotech Inc.
Tumor Markers - CA153/proGRP/CA242/PGI/PGII/Cy211 | Fapon Biotech Inc.

Markers of cancer stem cells of the female reproductive system | Download  Table
Markers of cancer stem cells of the female reproductive system | Download Table

Combining imaging- and gene-based hypoxia biomarkers in cervical cancer  improves prediction of chemoradiotherapy failure independent of intratumour  heterogeneity - eBioMedicine
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity - eBioMedicine

Survival statistics for immunohistochemical markers in primary and... |  Download Table
Survival statistics for immunohistochemical markers in primary and... | Download Table

Diagnostic serum markers for cervical cancer in clinical use. | Download  Table
Diagnostic serum markers for cervical cancer in clinical use. | Download Table

Oncology
Oncology

Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based  on Systems Biology Technologies - ScienceDirect
Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect

IJMS | Free Full-Text | Viral-Cellular DNA Junctions as Molecular Markers  for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the  Detection of Circulating Tumor DNA
IJMS | Free Full-Text | Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA

Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and  pβ-Cat675 are prognostic biomarkers of cervical cancer - eBioMedicine
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer - eBioMedicine

Selective Markers of Human Epithelial Stem Cells in Cervical Cancer |  Download Table
Selective Markers of Human Epithelial Stem Cells in Cervical Cancer | Download Table

Single-cell transcriptomics reveals the landscape of intra-tumoral  heterogeneity and transcriptional activities of ECs in CC: Molecular  Therapy - Nucleic Acids
Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in CC: Molecular Therapy - Nucleic Acids

Identification of miRNAs in cervical mucus as a novel diagnostic marker for  cervical neoplasia | Scientific Reports
Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia | Scientific Reports

Ovarian tumor markers: What to draw and when | MDedge ObGyn
Ovarian tumor markers: What to draw and when | MDedge ObGyn

Currently available and potentially useful serum markers for cervical... |  Download Table
Currently available and potentially useful serum markers for cervical... | Download Table

Protein expression of IDO1 and gene markers in cervical cancer tissue... |  Download Scientific Diagram
Protein expression of IDO1 and gene markers in cervical cancer tissue... | Download Scientific Diagram

Molecular diagnostic assays for cervical neoplasia: emerging markers for  the detection of high-grade cervical disease | BioTechniques
Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease | BioTechniques

Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical  Cancer | Anticancer Research
Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical Cancer | Anticancer Research

Frontiers | The Relevant Participation of Prolactin in the Genesis and  Progression of Gynecological Cancers
Frontiers | The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers

Patient-derived organoids model cervical tissue dynamics and viral  oncogenesis in cervical cancer - ScienceDirect
Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer - ScienceDirect

Noninvasive Point-of-Care Nanobiosensing of Cervical Cancer as an Auxiliary  to Pap-Smear Test | ACS Applied Bio Materials
Noninvasive Point-of-Care Nanobiosensing of Cervical Cancer as an Auxiliary to Pap-Smear Test | ACS Applied Bio Materials